Abivax (AAVXF) Prepaid Assets (2024 - 2026)
Abivax (AAVXF) posted Prepaid Assets of $41.9 million for Q1 2026, up 4.06% on a QoQ basis from $40.3 million in Q4 2025.
Analysis
Abivax (AAVXF) Prepaid Assets (2024 - 2026) Analysis & Trends
Abivax has reported Prepaid Assets for 3 years, with the latest figure at $41.9 million in Q1 2026.
- On a quarterly basis, Prepaid Assets changed N/A year-over-year to $41.9 million in Q1 2026; TTM through Mar 2026 was $41.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $40.3 million, up 42.77% from the prior year.
- Prepaid Assets was $41.9 million for Q1 2026 at Abivax, up from $40.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $41.9 million in Q1 2026, with the low at $28.2 million in Q4 2024.
- Average Prepaid Assets over 3 years is $36.8 million, with a median of $40.3 million recorded in 2025.
- The largest YoY upside for Prepaid Assets was 42.77% in 2025 against a maximum downside of 42.77% in 2025.
- Over 3 years, Prepaid Assets stood at $28.2 million in 2024, then jumped by 42.77% to $40.3 million in 2025, then grew by 4.06% to $41.9 million in 2026.
- The last three Prepaid Assets figures came in at $41.9 million (Q1 2026), $40.3 million (Q4 2025), and $28.2 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 41.91 Mn |
| Dec 31, 2025 | 40.28 Mn |
| Dec 31, 2024 | 28.21 Mn |